Video

Transitioning Care for Adult Patients With Sickle Cell Anemia

The vast majority of clinicians who are familiar with sickle cell anemia are pediatricians, leading to substantial transitions of care concerns in adult patients, states Thomas D. Coates, MD. As a result, there are few experts to which pediatricians can refer their patients once they reach adulthood.

The lack of expertise among clinicians who treat adults means that children with sickle cell anemia need to be taught how to manage their own disease. However, complications can occur, and many patients ultimately seek care in the emergency department. As a result, explains Coates, adult patients may receive suboptimal care that increases their risk of mortality.

Although a minority of patients have access to the procedure, bone marrow transplantation is curative in sickle cell disease. One recent advancement on the horizon is gene therapy, adds Coates, which involves autologous hematopoietic stem cell transplantation with corrected genes.

Related Videos
Ashkan Emadi, MD, PhD
Javier Pinilla, MD, PhD, and Talha Badar, MBBS, MD, discuss factors that influence later-line treatment choices in chronic myeloid leukemia.
Javier Pinilla, MD, PhD, and Talha Badar, MBBS, MD, on the implications of the FDA approval of asciminib in newly diagnosed CP-CML.
Duvelisib in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma
Eunice S. Wang, MD
Nosha Farhadfar, MD, and Chandler Park, MD, FACP
Eunice Wang, MD, and Chandler Park, MD, FACP
Muhamed Baljevic, MD, FACP and Jorge Cortes, MD, discuss upcoming studies and emerging data being presented at the 2024 ASH Annual Meeting.
Minoo Battiwalla, MD, MS
Farrukh Awan, MD, discusses treatment considerations with the use of pirtobrutinib in previously treated patients with hematologic malignancies.